Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Ocugen Stock Surged Today

TheMotleyFool

0 0

Why Ocugen Stock Surged TodayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Shares of Ocugen (NASDAQ: OCGN) climbed on Wednesday after the biopharmaceutical company's partner, Bharat Biotech, released promising results from a phase 3 trial of its COVID-19 vaccine candidate, Covaxin.

As of 3 p.m. EDT, Ocugen's stock price was up more than 12% after rising as much as 22.5% earlier in the day.

A second interim analysis of a phase 3 study with 25,800 participants showed Covaxin to have efficacy against mild, moderate, and severe COVID-19 of 78%. Against severe COVID-19 alone, that figure came in at 100%.

Source Fool.com

Like: 0

OCGN

Teilen